ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – RAIN

NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19, 2023, both dates inclusive (the “Class Period”), of the important September 12, 2023 lead plaintiff deadline. SO WHAT: If you […]

Read More »

EB5 Capital’s Columbia Place (JF9) Project Receives I-829 Approvals

WASHINGTON, Aug. 03, 2023 (GLOBE NEWSWIRE) — Today, EB5 Capital announced that investors in its Columbia Place (JF9) project have started receiving I-829 approvals from the United States Citizenship and Immigration Services (USCIS). These approvals signify the investors’ eligibility for permanent residency, as they demonstrate the successful creation of at least ten full-time jobs for […]

Read More »

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Party City Holdco Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action– PRTY, PRTYQ

NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Party City Holdco Inc. (NYSE: PRTY) (OTC: PRTYQ) between November 8, 2022 and June 9, 2023, both dates inclusive (the “Class Period”). […]

Read More »

Abu Dhabi’s artificial intelligence university establishes dedicated robotics and computer science departments to meet surging global demand

ABU DHABI, United Arab Emirates, Aug. 03, 2023 (GLOBE NEWSWIRE) — Mohamed bin Zayed University of Artificial Intelligence (MBZUAI) has established two new departments and four associated graduate programs dedicated to robotics and computer science, catering to the surging global demand for these disciplines, which is expected to hit USD $225 billioni and $140 billion, respectively, […]

Read More »

The Coretec Group Launches its Endurion Partner Development Program

Company seeks interested third parties including end users, manufacturers, suppliers, and others across the EV and battery ecosystem ANN ARBOR, Mich., Aug. 02, 2023 (GLOBE NEWSWIRE) — The Coretec Group (OTCQB: CRTG), developers of silicon anode active materials for lithium-ion batteries and cyclohexasilane (CHS) for electric vehicles (EVs), cleantech, and emerging tech applications, today announced the launch […]

Read More »

Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet Rheumatology

Study found obexelimab produced rapid, strong, and sustained clinical improvement, including complete clinical remission, in most patients with active IgG4-RD Results support the continued development of obexelimab for the treatment of IgG4-RD and potentially other B cell-mediated autoimmune conditions WALTHAM, Mass., Aug. 01, 2023 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to […]

Read More »